Clinical Trials Detalhe
Study of the Efficacy and Safety of MEDI4893
Visão Geral
Gender
ALL
Idade
from 18 Years to 130 Years
Fase
PHASE2
Tipo de estudo
INTERVENTIONAL
Localização
Research Site (Ponte de Lima, Portugal)
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT02296320Sumário
Clinical trial looking at safety and efficacy of MEDI4893 in prevention of pneumonia caused by Staphylococcus aureus in high-risk patients
Condições
Staphylococcus Aureus Pneumonia
Elegibilidade
Inclusion Criteria: * Colonized with Staphylococcus aureus, expected to require prolonged intubation and mechanical ventilation, without any evidence of active pneumonia. Exclusion Criteria: * Staphylococcal disease at randomisation; lung injury score consistent with pneumonia; current lung disease; chronic tracheostomy patients; currently receiving systemic anti-staphylococcal antibiotics; moribund patients.